RSVP: Developments in Prescription Drug Pricing under the Second Trump Administration
Three experts join Larry Levitt, executive vice president for health policy at KFF, for a 45-minute “Health Wonk Shop” discussion about the latest developments in prescription drug pricing and what they mean for drug manufacturers, patients and public and private health insurance programs. Register to attend this virtual event.
